The Biotech Stock Defying Expectations: Recursion Pharmaceuticals Soars Amid AI Revolution
Recursion Pharmaceuticals experiences a 23.88% increase in stock value, reflecting its innovative approach in the biotech landscape. The company leverages automation and AI through its proprietary operating system to discover…